Latest debt-to-equity ratio
Black Diamond Therapeutics Debt-to-equity ratio
Direct answer
Black Diamond Therapeutics's debt-to-equity ratio is 17.66%.
The verified market snapshot reports 17.66%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 26, 2026.
Get free Black Diamond Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 17.66%
Explore related company data
View Black Diamond Therapeutics's market capitalizationView Black Diamond Therapeutics's price-to-book ratioView Black Diamond Therapeutics's return on equityView Black Diamond Therapeutics's dividend yieldView Black Diamond Therapeutics's 52-week price rangeView Black Diamond Therapeutics's profit marginView all Black Diamond Therapeutics key metricsReturn to Black Diamond Therapeutics profile